ğŸ“Š Multi-Faceted Pharmaceutical Business Intelligence Project

This project demonstrates a comprehensive Business Intelligence (BI) pipeline for the pharmaceutical domain, integrating data analysis, machine learning, time-series forecasting, and natural language processing (NLP) to deliver actionable insights across clinical, commercial  areas.

ğŸš€ Project Overview

The project leverages Python libraries such as Pandas, NumPy, Scikit-learn, and Statsmodels to analyze multiple datasets from an SQLite database (pharma.db).

It covers:

ğŸ‘¥ Patient segmentation & heart disease risk prediction

ğŸ’Š Drug sales forecasting

ğŸ“‘ Adverse Event (AE) classification with NLP

This multi-faceted approach helps pharmaceutical stakeholders in clinical decision-making, commercial planning, and pharmacovigilance.

ğŸ“‚ Datasets

Five datasets are used in this project:

patients â€“ Demographic & health info for 5,000 patients (age, sex, BMI, conditions like diabetes, heart disease).

labs â€“ Lab test results (LDL, HDL, HbA1c) with 10,000+ entries.

prescriptions â€“ Drug prescriptions (drug name, dose, therapeutic area, class) with 7,500+ records.

sales_monthly â€“ Monthly drug sales over time (165 entries).

ae_reports â€“ 2,000 adverse event reports labeled as serious or nonserious.

âœ… Initial checks confirmed no missing values or duplicates.

ğŸ› ï¸ Data Preparation & Feature Engineering

Lab data merge â€“ Added latest LDL, HDL, HbA1c results per patient.

Prescription feature â€“ Created a binary variable ever_statin to indicate statin history.

Categorical encoding â€“ Converted sex (M/F) to numeric values.

Outlier handling â€“ Used Z-score detection & capping at 1st/99th percentiles to mitigate extreme values.

â¤ï¸ Heart Disease Risk Prediction

A classification pipeline was built to predict heart disease (heart_disease column).

Challenge: Highly imbalanced target â†’ addressed using SMOTE oversampling.

Models Trained:

Logistic Regression â†’ Accuracy: 74%, Recall (positive class): 79%

Random Forest â†’ Accuracy: 94%, Balanced F1-score: 0.58

Gradient Boosting â†’ Accuracy: 85%, Recall (positive class): 52%

ğŸ” Explainability:
Used SHAP values â†’ Key predictors: Age, Cholesterol, BMI.

ğŸ“ˆ Drug Sales Forecasting

SARIMA models were applied on monthly sales data for drugs with â‰¥24 months history.

Seasonal order: (1,1,1,12) â†’ capturing yearly trends.

Metrics used: RMSE, MAE, MAPE.

Results:

ATORVASTATIN â†’ MAPE: 3.7% (high accuracy)

METFORMIN â†’ MAPE: 5.6%

ALBURX â†’ MAPE: 11.5%

ğŸ“Š Insight: Reliable sales forecasts support inventory & demand planning.

ğŸ§  NLP for Adverse Event Classification

Built an NLP pipeline to classify AE reports as serious or nonserious.

Preprocessing: Lowercasing, tokenization, lemmatization.

Vectorization: TF-IDF features.

Model: Logistic Regression (class weights balanced).

Performance:

Accuracy: 86%

F1 Score: 0.87

ROC-AUC: 0.88

âš•ï¸ Insight: Automating AE triage helps prioritize urgent safety cases.

âœ… Key Outcomes

Patient Risk Prediction â€“ Identified critical risk factors for heart disease.

Sales Forecasting â€“ Produced accurate demand predictions for key drugs.

Pharmacovigilance NLP â€“  AE classification model with strong performance.

ğŸ› ï¸ Tech Stack

Data Handling: Pandas, NumPy, SQLite

Modeling: Scikit-learn, Imbalanced-learn (SMOTE), Statsmodels (SARIMA)

Explainability: SHAP

Visualization: Matplotlib, Seaborn

NLP: TF-IDF, Logistic Regression

ğŸ“Œ Conclusion

This project demonstrates how integrating ML, time-series forecasting, and NLP into a unified BI pipeline can create a powerful decision-support system for pharmaceutical companies.

